الفهرس 
REVIEW OF LITERATUREOnly 14 pages are availabe for public view
 |  | from | 154 |  |  |
| | | from | 154 | | |
Abstract
Neonatal sepsis remains a major clinical problem in neonatology, with
high morbidity and mortality rates despite the progress in neonatal
intensive care and antibiotics. The host defense against infections is
immature in the newborn infant, and this makes the neonate more
susceptible to intensive infection.
The diagnosis of neonatal sepsis begins with clinical suspicion. The
challenge for the neonatal practitioner is to decide which babies need
empirical antibiotic therapy but this causes antibiotic overuse and
nosocomial infections because of unnecessary hospitalization.
Unfortunately there is no single diagnostic test, which can reliably
diagnose sepsis in the newborn, therefore many diagnostic tests are
utilized to diagnose or confirm sepsis.
This study was conducted in order to evaluate the prognostic value of
Antithrombin III in neonatal sepsis.
The present study was carried out at the neonatal intensive care unit
(NICU) Shebin El-Kom Teaching Hospital during the period from
June 2010 to June 2011. This study includes:
Group I :-( STUDY GROUP)
It included 40 neonates with sepsis 19 of them survived ,21 died,18
neonates was ill-septic and 22 neonates had DIC.
Group II :-( CONTROL GROUP)
It included 25 normal neonates.